NM57S/NC08

重组人源抗狂犬病毒单抗NM57S/NC08

Report date: 2025/04/28 22:35:30

Base Information

Drug NameNM57S/NC08
Drug Alias NameNM-57S/NC-08
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionRabies virus neutralization
TargetsRabies virus
Therapy Area/IndicationsRabies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesNorth China Pharmaceutical Company Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesNorth China Pharmaceutical Company LtdNorth China Pharmaceutical Group New Drug R&D Co Ltd
Inactive CompaniesN/A
Active IndicationsRabies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A